Interleukin-15 in Outcomes of Pregnancy

Int J Mol Sci. 2021 Oct 14;22(20):11094. doi: 10.3390/ijms222011094.

Abstract

Interleukin-15 (IL-15) is a pleiotropic cytokine that classically acts to support the development, maintenance, and function of killer lymphocytes. IL-15 is abundant in the uterus prior to and during pregnancy, but it is subject to tight spatial and temporal regulation. Both mouse models and human studies suggest that homeostasis of IL-15 is essential for healthy pregnancy. Dysregulation of IL-15 is associated with adverse outcomes of pregnancy. Herein, we review producers of IL-15 and responders to IL-15, including non-traditional responders in the maternal uterus and fetal placenta. We also review regulation of IL-15 at the maternal-fetal interface and propose mechanisms of action of IL-15 to facilitate additional study of this critical cytokine in the context of pregnancy.

Keywords: CD122; Interleukin-15; inflammation; macrophages; natural killer cells; placenta; pregnancy; trophoblast.

Publication types

  • Review

MeSH terms

  • Animals
  • Female
  • Gene Expression Regulation
  • Humans
  • Interleukin-15 / physiology*
  • Mice
  • Placenta / physiology*
  • Pregnancy
  • Pregnancy Outcome
  • Uterus / physiology*

Substances

  • IL15 protein, human
  • Interleukin-15